JUN 24, 2019 02:36 PM PDT

Drug Combination May Combat Deadly Drug-Resistant Fungus

WRITTEN BY: Nouran Amin

A drug combination of anti-fungal and anti-bacterial medications may be effective against the spread of a highly infectious and deadly fungus--Candida auris (C. auris). According to the Centers for Disease and Control, C. auris was first discovered in Japan and has affected individuals in more than 20 countries and sickened 643 Americans in 11 U.S. states. The fungus has baffled health officials as the search for treatment options are higher than ever.

"Few treatment options are available for patients infected with Candida auris, which causes invasive, life-threatening infections, usually in patients who are already critically ill or have compromised immune systems," said Brennan-Krohn, MD, a post-doctoral research fellow in the lab of James E. Kirby, MD, Director of the Clinical Microbiology Laboratory at BIDMC. "It has an alarming propensity to spread from patient to patient and survive on surfaces in rooms, resulting in hospital outbreaks."

Findings presented at the annual meeting of the American Society for Microbiology discuss how the search for new treatment approaches allowed researchers to use a modified inkjet printer. The modified inkjet printer allows for rapid and uniform antimicrobial screening for the testing of antifungal drugs, amphotericin and caspofungin, in combination with two antibacterial antibiotics antibiotics, minocycline and rifampin,—to maximize the efficacy against fungal infections. Results showed three new combinations of antifungal and antibacterial drugs that demonstrated effectiveness against C. auris.

Although the dugs have not been tested in combination in C. auris-infected humans, the drugs are actually FDA-approved and presently prescribed for patients with a variety of infections.

However, if the drugs prove to eradicate C. auris infections in clinical studies, then physicians already have access to the effective treatment for their patients infected with C. auris.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 20, 2020
Technology
JAN 20, 2020
New Encapsulation Technology
Research at the University of Waterloo has concluded new encapsulation technology that can offer an inexpensive, and effective method for coating liquid me...
JAN 20, 2020
Drug Discovery & Development
JAN 20, 2020
Cone Snail Venom Became and Pain Therapeutics
Ever heard of conotoxins? They are bioactive peptides present in the venom of the predatory marine cone snails that are well known for their effective enve...
JAN 20, 2020
Cannabis Sciences
JAN 20, 2020
Cannabis Can't Simply Replace Opioids for Pain Management
According to the research, cannabis is not effective when it comes to treating individuals struggling with opioid use disorder. While some may have conside...
JAN 20, 2020
Health & Medicine
JAN 20, 2020
Federal Government Weighs in on Marijuana and Opioid Addiction
The U.S. government is weighing in on the hot topic of whether or not medical marijuana is a successful tool in treating opioid addiction by barring the us...
JAN 20, 2020
Drug Discovery & Development
JAN 20, 2020
IV Treatment for Traumatic Brain Injury
Scientists are now using exosomes intravenously as a method of cell-to-cell technology for treating patients with traumatic brain injury (TBI). They discov...
JAN 20, 2020
Drug Discovery & Development
JAN 20, 2020
Can Silica Treat Obesity and Diabetes?
Silica particles, specifically ‘mesoporous silica particles (MSPs)’ are engineered molecular traps that may provide a breakthrough treatment op...
Loading Comments...